Steven Feinstein to Cardiovascular Diseases
This is a "connection" page, showing publications Steven Feinstein has written about Cardiovascular Diseases.
Connection Strength
1.221
-
Drug and Gene Delivery using Sonoporation for Cardiovascular Disease. Adv Exp Med Biol. 2016; 880:331-8.
Score: 0.379
-
New advances in noninvasive imaging of the carotid artery: CIMT, contrast-enhanced ultrasound, and vasa vasorum. Curr Cardiol Rep. 2010 Nov; 12(6):497-502.
Score: 0.265
-
Emerging, noninvasive surrogate markers of atherosclerosis. Curr Atheroscler Rep. 2004 Jan; 6(1):60-8.
Score: 0.165
-
Recommendations for the Assessment of Carotid Arterial Plaque by Ultrasound for the Characterization of Atherosclerosis and Evaluation of Cardiovascular Risk: From the American Society of Echocardiography. J Am Soc Echocardiogr. 2020 08; 33(8):917-933.
Score: 0.129
-
Chronic PM2.5 exposure and inflammation: determining sensitive subgroups in mid-life women. Environ Res. 2014 Jul; 132:168-75.
Score: 0.085
-
The role of carotid ultrasound in assessing carotid atherosclerosis in individuals at low-to-intermediate cardiovascular risk. Rev Esp Cardiol (Engl Ed). 2013 Dec; 66(12):929-34.
Score: 0.081
-
Vasa vasorum and plaque neovascularization on contrast-enhanced carotid ultrasound imaging correlates with cardiovascular disease and past cardiovascular events. Stroke. 2010 Jan; 41(1):41-7.
Score: 0.062
-
Role of surrogate markers in assessing patients with diabetes mellitus and the metabolic syndrome and in evaluating lipid-lowering therapy. Am J Cardiol. 2004 Jun 03; 93(11A):32C-48C.
Score: 0.042
-
Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes: a randomized trial. JAMA. 2006 Dec 06; 296(21):2572-81.
Score: 0.013